SignatureFD’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$79.5K Buy
879
+279
+47% +$25.6K ﹤0.01% 1464
2025
Q4
$54K Sell
600
-143
-19% -$13.6K ﹤0.01% 1603
2025
Q3
$73.2K Sell
743
-281
-27% -$27.8K ﹤0.01% 1442
2025
Q2
$93.4K Sell
1,024
-277
-21% -$26.8K ﹤0.01% 1264
2025
Q1
$147K Sell
1,301
-86
-6% -$9.2K ﹤0.01% 1024
2024
Q4
$147K Sell
1,387
-471
-25% -$50.5K ﹤0.01% 1030
2024
Q3
$201K Sell
1,858
-325
-15% -$35.5K ﹤0.01% 859
2024
Q2
$237K Sell
2,183
-278
-11% -$32.8K ﹤0.01% 744
2024
Q1
$325K Buy
2,461
+315
+15% +$39.3K 0.01% 653
2023
Q4
$261K Buy
2,146
+243
+13% +$27.1K 0.01% 691
2023
Q3
$214K Sell
1,903
-354
-16% -$45K 0.01% 720
2023
Q2
$329K Buy
2,257
+501
+29% +$68.1K 0.01% 589
2023
Q1
$227K Buy
1,756
+131
+8% +$16.4K 0.01% 676
2022
Q4
$207K Buy
1,625
+23
+1% +$2.67K 0.01% 698
2022
Q3
$167K Sell
1,602
-390
-20% -$42.8K 0.01% 744
2022
Q2
$209K Sell
1,992
-87
-4% -$10.3K 0.01% 686
2022
Q1
$266K Buy
2,079
+200
+11% +$24.1K 0.01% 625
2021
Q4
$232K Buy
1,879
+27
+1% +$3.53K 0.01% 663
2021
Q3
$263K Buy
1,852
+21
+1% +$3.09K 0.01% 579
2021
Q2
$286K Buy
1,831
+142
+8% +$23K 0.01% 527
2021
Q1
$263K Sell
1,689
-220
-12% -$34.1K 0.01% 492
2020
Q4
$286K Sell
1,909
-171
-8% -$24.2K 0.01% 426
2020
Q3
$275K Buy
2,080
+541
+35% +$70.7K 0.01% 374
2020
Q2
$178K Buy
1,539
+285
+23% +$32.8K 0.01% 492
2020
Q1
$123K Buy
1,254
+342
+38% +$44.8K 0.01% 564
2019
Q4
$132K Buy
912
+63
+7% +$8.7K 0.01% 602
2019
Q3
$113K Buy
849
+14
+2% +$1.81K 0.01% 600
2019
Q2
$95K Sell
835
-387
-32% -$45.3K 0.01% 649
2019
Q1
$151K Buy
1,222
+31
+3% +$3.52K 0.01% 481
2018
Q4
$120K Buy
1,191
+20
+2% +$2.25K 0.01% 518
2018
Q3
$149K Sell
1,171
-3,235
-73% -$385K 0.02% 507
2018
Q2
$477K Buy
4,406
+469
+12% +$51K 0.05% 182
2018
Q1
$417K Buy
3,937
+181
+5% +$21K 0.05% 172
2017
Q4
$440K Buy
3,756
+73
+2% +$8.26K 0.05% 167
2017
Q3
$419K Sell
3,683
-393
-10% -$45.4K 0.06% 155
2017
Q2
$508K Buy
4,076
+10
+0.2% +$1.19K 0.07% 111
2017
Q1
$482K Buy
4,066
+91
+2% +$10.3K 0.07% 122
2016
Q4
$398K Buy
3,975
+3,215
+423% +$345K 0.07% 118
2016
Q3
$96K Buy
760
+340
+81% +$42K 0.01% 373
2016
Q2
$49K Sell
420
-39
-8% -$4.41K 0.01% 491
2016
Q1
$48K Sell
459
-30
-6% -$2.9K 0.01% 441
2015
Q4
$49K Buy
489
+79
+19% +$7.73K 0.01% 377
2015
Q3
$37K Buy
410
+93
+29% +$9.32K 0.01% 406
2015
Q2
$34K Buy
317
+86
+37% +$9.52K 0.01% 387
2015
Q1
$26K Buy
231
+115
+99% +$13.1K 0.01% 388
2014
Q4
$13K Buy
116
+20
+21% +$2.11K ﹤0.01% 469
2014
Q3
$9K Hold
96
﹤0.01% 474
2014
Q2
$10K Hold
96
﹤0.01% 463
2014
Q1
$9K Hold
96
﹤0.01% 434
2013
Q4
$9K Sell
96
-139
-59% -$12K ﹤0.01% 455
2013
Q3
$19K Buy
235
+194
+473% +$15.3K 0.01% 342
2013
Q2
$3K Buy
+41
New +$3.07K ﹤0.01% 455

Other funds holding ZBH

SignatureFD's ZBH Position: Q1 2026 in Review

SignatureFD increased its Zimmer Biomet (ZBH) stake by 47% in Q1 2026, buying an estimated $25.6K and bringing the position to 879 shares worth $79.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1464.

SignatureFD first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $508K in Q2 2017. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • SignatureFD held 879 shares of Zimmer Biomet worth $79.5K as of Q1 2026.
  • SignatureFD bought 279 Zimmer Biomet shares in Q1 2026, an estimated $25.6K.
  • Zimmer Biomet made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #1464 holding.
  • SignatureFD first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • SignatureFD's Zimmer Biomet position peaked at $508K in Q2 2017.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.